| Product Code: ETC7223126 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Medication Assisted Treatment Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Medication Assisted Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 France Medication Assisted Treatment Market - Industry Life Cycle |
3.4 France Medication Assisted Treatment Market - Porter's Five Forces |
3.5 France Medication Assisted Treatment Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.6 France Medication Assisted Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 France Medication Assisted Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 France Medication Assisted Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 France Medication Assisted Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of medication-assisted treatment (MAT) in France |
4.2.2 Government initiatives and policies promoting MAT programs in the country |
4.2.3 Growing prevalence of substance abuse disorders and opioid addiction in France |
4.3 Market Restraints |
4.3.1 Stigma associated with MAT among patients and healthcare providers |
4.3.2 Limited access to MAT services in rural or underserved areas of France |
4.3.3 Regulatory challenges and stringent guidelines for MAT implementation |
5 France Medication Assisted Treatment Market Trends |
6 France Medication Assisted Treatment Market, By Types |
6.1 France Medication Assisted Treatment Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 France Medication Assisted Treatment Market Revenues & Volume, By Products, 2021- 2031F |
6.1.3 France Medication Assisted Treatment Market Revenues & Volume, By Buprenorphine and Naloxone, 2021- 2031F |
6.1.4 France Medication Assisted Treatment Market Revenues & Volume, By Naltrexone, 2021- 2031F |
6.1.5 France Medication Assisted Treatment Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.6 France Medication Assisted Treatment Market Revenues & Volume, By Methadone, 2021- 2031F |
6.2 France Medication Assisted Treatment Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 France Medication Assisted Treatment Market Revenues & Volume, By Generics, 2021- 2031F |
6.2.3 France Medication Assisted Treatment Market Revenues & Volume, By Branded, 2021- 2031F |
6.3 France Medication Assisted Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 France Medication Assisted Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 France Medication Assisted Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 France Medication Assisted Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 France Medication Assisted Treatment Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 France Medication Assisted Treatment Market Revenues & Volume, By Rehabilitation Clinics, 2021- 2031F |
6.4.3 France Medication Assisted Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 France Medication Assisted Treatment Market Revenues & Volume, By Specialty Centers, 2021- 2031F |
6.4.5 France Medication Assisted Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.6 France Medication Assisted Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 France Medication Assisted Treatment Market Import-Export Trade Statistics |
7.1 France Medication Assisted Treatment Market Export to Major Countries |
7.2 France Medication Assisted Treatment Market Imports from Major Countries |
8 France Medication Assisted Treatment Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare facilities offering MAT in France |
8.2 Average wait times for patients seeking MAT services |
8.3 Percentage of MAT program participants successfully completing treatment |
8.4 Rate of relapse among MAT program graduates |
8.5 Patient satisfaction scores with MAT services provided |
9 France Medication Assisted Treatment Market - Opportunity Assessment |
9.1 France Medication Assisted Treatment Market Opportunity Assessment, By Products, 2021 & 2031F |
9.2 France Medication Assisted Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 France Medication Assisted Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 France Medication Assisted Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
10 France Medication Assisted Treatment Market - Competitive Landscape |
10.1 France Medication Assisted Treatment Market Revenue Share, By Companies, 2024 |
10.2 France Medication Assisted Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here